Get startedLog in
    Picture of 3D Medicines logo

    1244 — 3D Medicines Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for 3D Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSARSARSARSARS
    Standards:
    IFRS    		—
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-1,462-1,052-562-199-185
    Depreciation
    Amortisation
    Non-Cash Items1,1127592828.9820.7
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-39.9-7.35111-45.4-10.1
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-377-279-144-211-159
    Capital Expenditures-44.9-54-6.32-1.46-0.024
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-54-188-18119.4-21.4
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-98.9-242-18818-21.5
    Financing Cash Flow Items309-24.211.5-0.7531.8
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities840408305-33.9-91.9
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash360-77.6-30.3-222-274